The causal link between a pathogen's gene and virulence can be established by fulfilling Molecular Koch's Postulates, which, in turn, requires the engineering of targeted mutations in the predicted gene of interest. Within the past decade, the paradigm-shifting and revolutionary technology of recombineering has enabled bacteriologists to construct virtually every conceivable mutation in many enteric bacteria. Recombineering exploits the function of bacteriophage-encoded recombinases to bring about allelic replacement. In recombineering, a linear double stranded or single stranded DNA molecule with terminal homology arms, identical to the region upstream and downstream of a genetic locus of interest, is introduced into hyperrecombinogenic bacteria. Recombinases catalyze the replacement of the genomic allele with the introduced allele. Using this technique, bacteriologists have methodically dissected the virulome of the attaching and effacing (A/E) pathogens including enterohemorrhagic Escherichia coli (EHEC), enteropathogenic E. coli (EPEC), and Citrobacter rodentium. In contrast, the virulome of the most recent family member, E. albertii, remains unmapped, despite metagenomic sequencing revealing that the bacterium possesses an impressive arsenal of virulence determinants. Consistent with these observations, retrospective studies have incriminated E. albertii as the etiologic agent of multiple disease outbreaks in both developed and developing countries. Therefore, it is imperative to initiate studies to interrogate its virulence mechanisms for developing effective interventions. With this in mind, we developed a protocol employing lambda red-mediated recombineering to identify and characterize virulence genes in the bacterium. The versatility of recombineering for targeted mutagenesis was demonstrated by allelic replacement of multiple unlinked genetic loci with a noted role in virulence of related A/E pathogens. Our protocol will enable researchers to mutagenize any gene in E. albertii to understand its contribution to bacterial pathophysiology.
Introduction
The Gram-negative bacterium Escherichia albertii was originally isolated by John Albert and his collaborators in 1991 from stool samples of Bangladeshi children suffering from diarrhea [1, 2] . These isolates were tentatively designated Hafnia alvei based upon preliminary genotypic and phenotypic characterization [1, 2] . However, subsequent systematic characterization of these isolates, using more comprehensive panels of biochemical and genetic assays, revealed that these isolates were phylogenetically more closely related to the genera Escherichia and were, therefore, rechristened Escherichia albertii [3] [4] [5] [6] . One of the striking pathological traits exhibited by the original isolates was their ability to induce diarrhea in rabbits [1, 2] . Histological and microscopic analysis of the infected intestines from these diarrheic rabbits revealed the presence of attaching and effacing (A/E) lesions [1, 2] . A/E lesions are pathomorphological organelles of gastrointestinal pathogens including enteropathogenic Escherichia coli (EPEC), enterohemorrhagic Escherichia coli (EHEC), and Citrobacter rodentium [7] [8] [9] . The ability of A/E pathogens to form such lesions stems from the pathogenicity island locus of enterocyte effacement (LEE) [7] [8] [9] . The LEE encodes the proteinaceous components of a type III secretion system (T3SS) that assembles in the bacterial extracytoplasmic space and extends through the extracellular milieu to perforate the host cell membrane. The T3SS enables the pathogen to translocate a panel of structurally and functionally diverse effector molecules into the host. These effectors hijack host signaling pathways that leads to bacterial infection, destruction of microvilli, diarrhea, and in some cases death [7] [8] [9] [10] [11] .
The LEE is necessary for the virulence of EPEC, EHEC, and C. rodentium. Consequently, this genetic module has been the subject of intense regulatory, structural, and mechanistic studies ever since its pathophysiological significance was recognized [7-9, 12, 13] . The external physiochemical cues and their cognate signal transduction pathways that converge on the LEE have been systematically characterized in the aforementioned A/E pathogens. Between the three pathogens, over fifty regulators of the LEE, operating at every hierarchical level of gene expression, have been identified [7-9, 12, 13] . The data reveal an ornate regulatory web, responsive to an equally diverse array of environmental cues, which enacts a highly plastic pattern of gene expression from the LEE.
In contrast to EPEC, EHEC, and C. rodentium, there is paucity of information on regulation of the LEE in E. albertii to the extent that, to date, not a single regulator has been identified. Besides the LEE, the genome of E. albertii also harbors other virulence determinants. For instance, a stx 2a -expressing E. albertii strain was recently isolated from a patient with bloody diarrhea [14] . Stx2a is a very potent toxin, which, besides the genus Shigella, has traditionally been associated with EHEC [14] [15] [16] . Bacteria that express stx 2a are characterized as highly virulent because they can induce the life-threatening pathology of hemolytic uremic syndrome (HUS) [17, 18] . Additional virulence factors, including the presence of a second type III secretion system (ETTS) and the genes for the cytolethal-distending toxin are also encoded in the genome of E. albertii [19] . This impressive array of virulence factors appears to be but the tip of the iceberg, since the mining of its pangenome has only just begun [19] . Given the diversity of its virulence factors it comes as no surprise that E. albertii has been implicated as the etiologic agent for multiple outbreaks of gastroenteritis in both developing and developed nations [20] [21] [22] . Other reports also suggest a probable link between the bacterium and death in birds [23] . Collectively, these data suggest that E. albertii is a rapidly emerging bacterial pathogen with a broad host range whose epidemiology, infectivity, incidence, and virulence potential remain uncharacterized. This is cause for concern, because a major outbreak of E. albertii may lead to considerable morbidity and mortality. In the absence of suitable preventative and therapeutic strategies, health care practitioners may be resigned to indiscriminate prescription of antibiotics. This will, undoubtedly, lead to the eventual emergence of multidrug resistance in the bacterium sooner rather than later, as has been reported for other pathogens [24] .
The ability to engineer site-specific mutations in the genome of a pathogen is vital towards fulfilling "Molecular Koch's" postulates to unequivocally demonstrate the role of a gene in virulence [25, 26] . Within the past decade, the versatile and revolutionary genome editing technology of recombineering has been extensively used to test molecular Koch's postulates [9, [27] [28] [29] [30] . In recombineering, bacteriophage-encoded recombinase enzymes are employed for modification of the bacterial endogenote [27, [31] [32] [33] [34] [35] [36] [37] . The red recombinase enzyme, specified by the bacteriophage lambda, is the preferred tool for bacteriologists studying enteropathogens [29, 30, 34] . Expression of the lambda red recombinase proteins from a plasmid or episome engineers a hyperrecombinogenic physiological state in the bacterium. These cells are subsequently made electrocompetent and transformed with a linear double stranded (ds) or single stranded (ss) DNA substrate encoding a selectable or screenable marker that is bracketed by two terminal homology arms [38] . Each arm contains ~40-50 nucleotides identical to the region upstream and downstream, respectively, of the genetic locus to be mutated [27, 28, 33, 38] .
The lambda red proteins catalyze the allelic replacement of the endogenous allele with the exogenous allele and successful mutants can be obtained on suitable selective and/or differential media. The three proteins -Exo, Beta, and Gam -constitute the lambda red recombinase [31-33, 35, 38] . Exo is ds-specific exonuclease that binds to the 5' end of the electroporated DNA substrate and processively cleaves nucleotides to generate a ssDNA intermediate [39, 40] . Beta, a single-stranded DNA annealing protein, coats the ssDNA intermediate and facilitates base-pairing with its complementary sequence to generate a heteroduplex [41, 42] . Meanwhile, Gam, an auxiliary component of the lambda red system, inactivates host exonucleases, including RecBCD and SbcCD, thereby protecting the transformed dsDNA substrate from degradation and consequently promoting homologous recombination [43, 44] . When the targeting Figure 1 . In recombineering, linear double stranded (ds) DNA (shown) or single stranded (ss) oligonucleotide (not shown) is used as a substrate to introduce targeted mutations by allelic replacement in a bacterium that expresses the lambda red recombinase. The substrates can be generated by PCR (shown) or restriction digestion (not shown) and contain a selectable (e.g. drug resistance cassette [drc] or prototrophy) or screenable (e.g. gfp) marker bracketed by two terminal homology arms of ~40-50 base pairs in length. One arm is identical to the region immediately upstream and the other immediately downstream of the locus (e.g. your favorite gene [yfg]) to be mutated. The lambda red enzymes catalyze allelic replacement of the genomic allele with the exogenous allele and recombinants are obtained by means of a selection or screen. Thereafter, the marker can be evicted and re-used if it is flanked by recognition target for a site-specific recombinase such as FLP. FLP recombinase catalyzes the site-specific recombination between two FLP recognition target (FRT) sites to excise the marker, leaving a residual FRT site in the excisant bacterium. The lambda red technique can be modified for engineering a range of marked and unmarked mutations. Refer to the following articles for the diverse applications of lambda red-mediated recombineering [27, 28, [31] [32] [33] 36] .
construct is dsDNA then all the three proteins are required for efficient recombination, however, Beta is sufficient when the substrate is ssDNA [37, [45] [46] [47] [48] .
Recombineering has enabled bacteriologists to unravel the spectrum of regulators that control the LEE in the A/E pathogens EPEC, EHEC, and C. rodentium [7-9, 12, 13, 27, 29, 30] . In stark contrast, the virulence regulatory network of E. albertii remains uncharacterized, to the extent that not a single regulator of the LEE has been identified. This limitation stems from the lack of a suitable molecular technique for targeted mutagenesis in the bacterium. As a consequence, the number and nature of virulence factors in E. albertii has merely been predicted by biocomputational approaches and correlation-based expression studies [19] . However, the litmus test, namely the construction of mutants and observation of pathophenotypic perturbations in the mutant with respect to the unaltered parent, has yet to be conducted.
Recently, we published a report in which we modified lambda red mediated recombineering for successful gene replacement with a drug resistance marker in E. albertii [28] . Subsequently, the marker was evicted by FLP-mediated site-specific recombination to generate excisants that are resensitized to the drug, thereby recycling the marker to construct additional mutations in the same bacterium [28] . Our results highlighted multiple environmental and genetic conditions essential for recombineering in E. albertii. First, and as has been documented in other bacteria, recombineering efficiencies were greatly affected by the plasmid vector used to express the lambda red genes [28] . For instance, we were only able to reproducibly engineer mutations when the lambda red genes were expressed from pSIM6 but not from the more commonly employed pKD46 plasmid vector. This result was perplexing since both replicons harbor the thermosensitive pSC101 origin of replication [33, 36] . The primary difference between the two replicons is that in pSIM6 the lambda red genes are under the transcriptional control of the temperature-responsive lambda repressor CI857 [36] , whereas in pKD46 the genes are controlled by the arabinose-responsive dual-transcription factor, AraC [33] . Our observations mirror the results obtained by another group that demonstrated that recombineering in E. coli is ~10 fold higher when the lambda red genes are expressed from a pSIM rather than from the pKD family of plasmids [36] . Additionally, we noted that the conditions that were permissive for recombineering in E. coli were largely nonpermissive for E. albertii and required further modification, such as prolonged induction of the lambda red genes, extended recovery time for the recombinants, and lower drug concentrations for enrichment of integrants [28, 36] . Second, recombination frequencies also depended upon the genetic locus that was mutagenized. For instance, many more recombinants were obtained when the LEE-encoded genetic loci ler or grlRA were deleted. On the other hand, when the non-LEE-encoded ancestral gene hfq was deleted the recombination frequency diminished precipitously [28] . Hfq is a pleiotropic regulator in E. coli, Salmonella Typhimurium, and other enterics and the amorphic hfq mutant exhibits a measurable growth defect [49] . Similarly, in E. albertii, the hfq mutant grows at an observably slower rate (unpublished observations) and this may, in part, explain the reduced recombination at this genetic locus.
Third, recombination frequency was ~4 orders of magnitude lower in E. albertii than what has previously been reported in E. coli, suggesting that the host genotype affects recombineering. A previous study in E. coli demonstrated that recombineering frequency is much higher when the recombination function is provided by recombinases that are native to the bacterium as opposed to heterologous recombinases [37] . E. coli is permissive to infection by lambda, whereas, under our tested experimental conditions, E. albertii was resistant to the bacteriophage (unpublished observations). Therefore it is expected that lambda red genes would be heterologous in E. albertii.
Significance
In summary, our recombineering protocol will enable bacteriologists to systematically mutagenize the genome of E. albertii and characterize its virulence factors. Moreover, besides deletions of genes, the same approach can be employed to engineer a spectrum of other genomic modifications including insertions, transcriptional and translational fusions, point mutations, and epitope tagged genes, all of which have been engineered in other bacterial species by recombineering [30, 34, 36, 38] . Thus, recombineering has far-reaching implications in rapidly broadening our knowledge of the biology of E. albertii. For instance, construction of single copy transcriptional, posttranscriptional, or translational fusions of an E. albertii gene with a native (e.g. lacZ) or heterologous (e.g. gfp) reporter gene in the chromosome would provide insight into the environmental stimuli and regulatory factors that affect the expression of the gene of interest. Similarly, a two-step recombineering protocol can be used to engineer markerless nonselectable mutations [38] . In this method, a cassette, containing a selectable and counterselectable marker, bracketed by an upstream and downstream homology arm is first introduced at the desired genetic locus by recombineering. Primary recombinant progeny are enriched by growth under conditions where the selectable marker is essential [38] . Next, hyperrecombinogenicity is re-induced in the mutants containing the cassette and they are transformed with a nonselectable allele containing two homology arms identical to those of the cassette. Secondary recombinants are counterselected under conditions in which expression of the counterselectable marker is lethal to the bacterium. Thus, any observed colonies are markerless excisants in which the entire cassette has been replaced with the desired nonselectable mutant allele (e.g. mutant that differs from the original parent by a single nucleotide substitution) [38] . This method can be employed for generating subtle mutations in the sequence or structural motifs in DNA, RNA, and proteins. In particular, mutations within conserved motifs in RNAs and proteins will be informative about the role of such motifs in influencing the structure, stability, and function of their cognate biomolecule. Recombineering would also benefit proteomic investigations of E. albertii. Biochemical reagents, such as antibodies against E. albertii-specific proteins, have yet to be developed and commercialized. As an alternative, recombineering can be used to tag chromosomal genes with a suitable epitope and the tagged recombinant protein can be biochemically purified by using commercial chromatographic columns for structural and mechanistic studies. Tagging proteins will also permit investigations into the abundance and/or half-life of E. albertii proteins by using antibodies against the epitope. Again, this approach circumvents the need to generate costly E. albertii specific antibodies. Thus, we anticipate that recombineering will pave the way for genome-wide investigations in E. albertii. The data obtained from these studies will be invaluable towards understanding the virulence, metabolism, ecology, and evolution of a bacterium, which, if unchecked, fosters the potential to become a global scourge.
Future studies
Current studies in our lab are focused on further enhancing recombineering in E. albertii by altering specific environmental and genetic parameters as outlined previously. In particular, we are experimenting with unmodified exonuclease-sensitive and covalently modified exonuclease-resistant ss-oligonucleotides as substrates for recombineering. Studies in E. coli suggest that recombineering frequency is ~2-3 orders of magnitude higher when ssDNA, rather than dsDNA, is used as the substrate for the recombinase [36, 37] . This has been observed regardless of whether the lambda red genes are expressed from a chromosomally embedded, but defective, prophage or from an extrachromosomal plasmid [36, 37] . Moreover, recombineering efficiency using ssDNA can be further elevated by protecting oligonucleotides from the repertoire of host-encoded exonucleases [50, 51] . One method of accomplishing this is by the introduction of phosphorothioate bonds in the 5' region of the oligonucleotide [50] .
Transformation of E. coli with oligonucleotides containing polyphosphorothioated linkages yields a higher number of recombinants compared to nonphosphorothioated oligonucleotides [50] . Similar studies on E. albertii are underway in our lab. Lastly, owing to the success of recombineering, we have initiated prospective studies to interrogate the regulatory architecture of the LEE in E. albertii. These studies will enable us to explore and elucidate the molecular mechanisms of virulence in E. albertii so that suitable interventional measures are in place to reduce morbidity and mortality from potential outbreaks of this bacterium.
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